MELISSA RUBIN: Open Payments
NPI 1346550571 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,405 in 118 payments from 19 companies in 2025. Trend: 2023 $173 · 2024 $919 · 2025 $2,405
Food & beverage: $2,214Education: $192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $511 |
| Janssen Biotech, Inc. | 20 | $341 |
| Regeneron Healthcare Solutions, Inc. | 7 | $207 |
| Incyte Corporation | 11 | $188 |
| UCB, Inc. | 13 | $155 |
| MERZ NORTH AMERICA, INC. | 1 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $143 |
| LEO Pharma Inc. | 1 | $141 |
| Amgen Inc. | 6 | $104 |
| PFIZER INC. | 4 | $75 |
Products named: SKYRIZI, TREMFYA, OPZELURA, Bimzelx, ADBRY, DUPIXENT, LIBTAYO, OTEZLA.
Industry payments across NJ — which companies pay providers there.
